Figure 1
Treatment regimen. (A) General schedule of dosimetry, radioimmunotherapy, and further conditioning. (B) Posterior view of a γ-camera image of patient A-8 demonstrating preferential accumulation in red BM 1 day after injection of 111In-labeled anti-CD66 monoclonal antibody. (C) Time schedule of the radioimmunotherapy (RIT) conditioning regimen.
